[HTML][HTML] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain, 2016 - pure.johnshopkins.edu
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
[PDF][PDF] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwardsa, RH Dworkinb, DC Turkc, MS Angstd… - 2016 - researchgate.net
There is tremendous inter-patient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain Reports, 2021 - vbn.aau.dk
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain, 2016 - pubmed.ncbi.nlm.nih.gov
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain, 2016 - europepmc.org
There is tremendous inter-patient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
[HTML][HTML] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - PAIN …, 2021 - journals.lww.com
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
[HTML][HTML] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain …, 2021 - ncbi.nlm.nih.gov
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain, 2016 - profiles.wustl.edu
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain …, 2021 - profiles.wustl.edu
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …
efficacious treatments), which can be the source of great frustration in clinical practice. This …